Glibclay 5 Tablet contains Glibenclamide 5mg, a widely prescribed sulfonylurea oral antidiabetic agent used for effective glycemic control in patients with type 2 diabetes mellitus. It works by stimulating insulin secretion from pancreatic beta cells, helping reduce high blood glucose levels.
The 5mg strength is commonly recommended for patients requiring strong glucose-lowering support as part of long-term diabetes management. Its well-documented clinical efficacy and predictable pharmacological action make it a trusted choice among physicians.
Glibenclamide tablets are routinely prescribed in diabetic clinics, general medicine practices, and multispecialty hospitals. Continuous usage in chronic diabetes care ensures steady demand across retail pharmacies, hospital pharmacies, and institutional buyers.
Adding Glibclay 5 Tablet to your diabetes and metabolic-care segment enhances your product portfolio and opens opportunities in pharmacy distribution, hospital supply chains, institutional procurement, export markets, and third-party manufacturing. Its consistent prescription volume makes it a commercially reliable antidiabetic product.